Protective Immune Mechanisms in Alcoholic Hepatitis

NCT01918462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2021-04-29

No results posted yet for this study

Summary

The purpose of this study is to investigate the production, effects and interactions of the hepato-protective cytokine interleukine (IL)-22 in patients with alcoholic hepatitis.

Conditions

  • Alcoholic Hepatitis

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Sidsel Støy, Phd student · Department of hepatology and gastroenterology, Aarhus University Hospital

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2018-04-20
Completion
2018-04-20

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01918462 on ClinicalTrials.gov